23.02.2013 Views

FOURTEENTH ANNUAL EUROPEAN PRESSURE ULCER ...

FOURTEENTH ANNUAL EUROPEAN PRESSURE ULCER ...

FOURTEENTH ANNUAL EUROPEAN PRESSURE ULCER ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Wednesday August 31st<br />

39<br />

14th Annual European Pressure Ulcer Meeting<br />

Oporto, Portugal<br />

ECONOMIC EVALUATION OF PREVENTION OF <strong>PRESSURE</strong> <strong>ULCER</strong>S IN INTENSIVE CARE UNITS<br />

Andrade, Melanie 1* , Nogueira, Fernanada 2 , Morais, Ernesto 3<br />

1* CHVNG/E, Portugal, andrade.melanie@gmail.com<br />

2 UTAD,Portugal 3 ESEP, Portugal<br />

Introduction<br />

The prevention of pressure ulcer assumes a fundamental role<br />

in health services economics and management, requiring the<br />

mobilization of material and human resources translated into<br />

significant costs for the institutions involved.<br />

As its aim this study had the determination and comparison<br />

of the costs and direct effects of pressure ulcer prevention<br />

with patients at risk of developing these ulcersm, admitted<br />

to two samples of an intensive care from different hospitals.<br />

Methods<br />

The methodology of this study was an economic evaluation,<br />

cost-effectiveness (CE), from the health institution view<br />

analysis, with patients admitted in intensive care units in<br />

two different hospitals CHVNG and in the HPH, between<br />

May and September 2009. The study population was 132<br />

patients (CHVNG) and 162 (HPH). The sample present<br />

inclusion criteria: patient without UP in admission moment<br />

and at risk of UP developing, with nursing intervention<br />

planed to prevent PU developing. The variables were related<br />

to the socio-biographical characteristics of patients, the costs<br />

of material and human resources recruited from the<br />

prevention PU programs and their direct effects (number of<br />

new cases, incidence and incidence density).<br />

Results<br />

The professional more important in prevention PU plan was<br />

the Nurse. We found that the samples had similar sociobiographical<br />

characteristics. They were hospitalized in ICU<br />

for around 6,7 days (CHVNG) and 5,9 (HPH). Diabetes is<br />

the predominant comorbidity in both samples. The patients’<br />

risk PU development was evaluated by Braden scale<br />

(CHVNG) and Norton scale (HPH). Considering the<br />

different risk PU development degree in each population,<br />

the difference between the averages of the daily frequency<br />

of the interventions for prevent PU development is not<br />

statistically significant. But, considering the two hospitals,<br />

the difference between the averages of daily frequency<br />

interventions was statistically significant - in the HPH,<br />

interventions were more frequently. Patients weren’t<br />

evaluated (using the scales) every days. The time of witch<br />

interventions, in the CHVNG was, for Position (position the<br />

patient, bed linen care) - 15 minutes, and in HPH - 19. For<br />

Monitoring scale was estimated 1,8 min in the CHVNG and<br />

5,87 min in HPH. Application of cream and massage was<br />

similar in both hospitals, 5,5 min in CHVNG and 5,9 in<br />

HPH.<br />

The total cost of PU prevention estimated was €20.915,36 in<br />

CHVNG and €42.100,69 in HPH. The cost of PU prevention<br />

per patient per day of hospitalization in ICU was €30,27 and<br />

€65,12, correspondingly. The human total cost represented<br />

almost 83% of the total cost, material/consumable (gloves,<br />

cream, apron and mask) 16% and material/equipment<br />

(mattress and pillows)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!